Naam
Personalized blended care for depression with comorbid alcohol misuse among young people: a multi-centre RCT
Afkorting
BLADE RCT
Beschrijving

Background: Depressive disorders and problematic drinking often co-occur, also among young adults. These co-occurring conditions are associated with various negative health outcomes compared to both conditions alone. Early intervention by addressing alcohol use and depressive symptoms simultaneously in the same treatment might improve both conditions. However, evidence on the (cost-) effectiveness of digital combined depression and alcohol interventions for young adults is currently insufficient. We therefore developed an add-on digital alcohol moderation adherence-focussed guided intervention to complement treatment as usual (TAU) for depressive disorders. The digital intervention is a web-app, including 6 modules based on motivational interviewing and cognitive behavioural therapy. This study aims to evaluate the (cost-)effectiveness of a digital alcohol moderation intervention + TAU compared to TAU on alcohol and depression outcomes among young adults with co-occurring depressive disorders and problematic alcohol use.

Methods: 163 participants, aged 18-35 years, with problematic alcohol use and a diagnosed depressive disorder will participate in a pragmatic multicentre two-arm randomized controlled trial. Problematic alcohol use is operationalised as scoring ≥5 for women and ≥ 8 for men on the Alcohol Use Disorder Identification Test (AUDIT). Participants will be randomized to either the experimental group (digital alcohol intervention + TAU) or control group (TAU only). Participants will be recruited at three Dutch mental health care centres and through social media. Assessments take place at baseline and after 3, 6 and 12 months post-randomization. The primary outcome is treatment response at 6-month follow-up, operationalized as a composite score that combines alcohol use and depression measures and indicates whether treatment has been successful or not. Secondary outcomes are depressive symptoms and alcohol use (i.e. number of weekly standard drinks and AUDIT score). An economic evaluation will be conducted alongside the trial.

Discussion: This study evaluates the (cost-) effectiveness of an add-on digital alcohol moderation intervention for young adults who are in treatment for depressive disorders. If proven effective, the digital intervention could be implemented in mental health care and improve treatment for people with co-occurring depressive disorders and problematic alcohol use.

Trial registration: Pre-registered on October 29, 2019 in The Netherlands Trial Register ( NL8122 ).

See also: https://pubmed.ncbi.nlm.nih.gov/34022840/

Gebruiksdoel

Medisch Wetenschappelijk Onderzoek

Operationeel
Nee
Contactgegevens publiek

Organisatie/instelling:

Arkin

Naam contactpersoon:

Dr. Matthijs Blankers

E-mail:

matthijs.blankers@arkin.nl

Adres:

Klaprozenweg 111

Postcode/plaats:

1033NN Amsterdam

URL website:

https://onderzoek.arkin.nl/

Beheerder gegevensbron
Arkin
Eigenaar gegevensbron
Arkin
Actualisatiedatum
07-11-2023
Wettelijke verplichting
Nee
Opdrachtgever(s)
Arkin
Belangrijkste financier(s)
ZonMw
Financier is overheid
Ja
Type gegevensverzameling
  • Longitudinale studie
  • ZonMw dataset
Gekoppelde categorieën
  • Functioneren en kwaliteit van leven
  • Geestelijke gezondheidszorg
  • Gezondheidsgedrag of leefstijl
  • Persoonsgebonden factoren
  • Preventie gericht op gedrag en leefstijl
Gekoppelde trefwoorden
Comorbiditeit
Geografische dekking
Nederland
Eenheden in de gegevens

163 Patienten

Methode van gegevensverzameling
Door een enquête en/of interview, electronisch patientendossier en logdata uit digitale behandeling
Type persoon/instelling die de gegevensbron invult

Onderzoekers en patienten (zelfrapportage vragenlijsten)

Specialisme
Psychiatrie
Sector
  • Eerstelijnszorg
  • Tweedelijnszorg
Eerste meetjaar
2020
Meest recente meetjaar
2022
Operationeel
Nee
Frequentie van aanleveren

Continu

Informatie die geregistreerd wordt
Jaar Aantal Steekproefgrootte Responspercentage Dekkingsgraad
2022 1 163 T0=100%, T1=85%, T2=83%
Beschikbaarheid gegevens
Ja
Voorwaarden beschikbaarheid

Er zijn beperkingen aan de mogelijkheid patiëntendata aan derden beschikbaar te stellen. Per aanvraag/onderzoeksproject zal worden bezien of en zo ja welke data hiervoor beschikbaar kunnen worden gesteld.

Beschikbaarheid gegevens online
Nee
Contactgegevens publiek

Organisatie/instelling:

Arkin

Naam contactpersoon:

Dr. Matthijs Blankers

E-mail:

matthijs.blankers@arkin.nl

Adres:

Klaprozenweg 111

Postcode/plaats:

1033NN Amsterdam

URL website:

https://onderzoek.arkin.nl/

Afnemers/gebruikers
Zorgaanbieders
Producten die de gegevensbron gebruiken
Wetenschappelijke publicaties